China Pharma Holdings (CPHI) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for China Pharma Holdings (CPHI) over the last 11 years, with Q3 2025 value amounting to -$0.17.
- China Pharma Holdings' EPS (Weighted Average and Diluted) rose 7384.62% to -$0.17 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.41, marking a year-over-year increase of 16184.21%. This contributed to the annual value of -$0.27 for FY2024, which is 7032.97% up from last year.
- Per China Pharma Holdings' latest filing, its EPS (Weighted Average and Diluted) stood at -$0.17 for Q3 2025, which was up 7384.62% from -$0.16 recorded in Q2 2025.
- China Pharma Holdings' EPS (Weighted Average and Diluted)'s 5-year high stood at $1.98 during Q4 2024, with a 5-year trough of -$0.89 in Q2 2024.
- Its 3-year average for EPS (Weighted Average and Diluted) is -$0.13, with a median of -$0.24 in 2025.
- Over the last 5 years, China Pharma Holdings' EPS (Weighted Average and Diluted) had its largest YoY gain of 1000000.0% in 2024, and its largest YoY loss of 12413.79% in 2024.
- Over the past 3 years, China Pharma Holdings' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.02 in 2023, then surged by 10000.0% to $1.98 in 2024, then tumbled by 108.59% to -$0.17 in 2025.
- Its last three reported values are -$0.17 in Q3 2025, -$0.16 for Q2 2025, and -$0.24 during Q1 2025.